BE899667A - Nouveau complexe antibiotique antitumoral dit bbm-1675. - Google Patents
Nouveau complexe antibiotique antitumoral dit bbm-1675.Info
- Publication number
- BE899667A BE899667A BE0/212942A BE212942A BE899667A BE 899667 A BE899667 A BE 899667A BE 0/212942 A BE0/212942 A BE 0/212942A BE 212942 A BE212942 A BE 212942A BE 899667 A BE899667 A BE 899667A
- Authority
- BE
- Belgium
- Prior art keywords
- bbm
- complex
- antibiotic complex
- antitumor antibiotic
- new antitumor
- Prior art date
Links
- 239000003972 antineoplastic antibiotic Substances 0.000 title 1
- 208000008342 Leukemia P388 Diseases 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 230000004151 fermentation Effects 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49523183A | 1983-05-16 | 1983-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE899667A true BE899667A (fr) | 1984-11-16 |
Family
ID=23967812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/212942A BE899667A (fr) | 1983-05-16 | 1984-05-15 | Nouveau complexe antibiotique antitumoral dit bbm-1675. |
Country Status (28)
| Country | Link |
|---|---|
| JP (2) | JPS59232094A (cs) |
| KR (2) | KR840008817A (cs) |
| AT (1) | AT393691B (cs) |
| AU (1) | AU569294B2 (cs) |
| BE (1) | BE899667A (cs) |
| CA (1) | CA1241282A (cs) |
| CY (1) | CY1465A (cs) |
| DE (1) | DE3418023A1 (cs) |
| DK (1) | DK163127C (cs) |
| ES (1) | ES8700267A1 (cs) |
| FI (1) | FI81114C (cs) |
| FR (1) | FR2547594B1 (cs) |
| GB (1) | GB2141425B (cs) |
| GR (1) | GR81581B (cs) |
| HK (1) | HK9889A (cs) |
| HU (1) | HU193928B (cs) |
| IE (1) | IE57444B1 (cs) |
| IL (1) | IL71824A (cs) |
| IT (1) | IT1175498B (cs) |
| KE (1) | KE3846A (cs) |
| LU (1) | LU85362A1 (cs) |
| NL (1) | NL8401572A (cs) |
| NZ (1) | NZ208013A (cs) |
| PT (1) | PT78590A (cs) |
| SE (1) | SE460364B (cs) |
| SU (1) | SU1344249A3 (cs) |
| YU (1) | YU43846B (cs) |
| ZA (1) | ZA843591B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR78648B (cs) * | 1982-07-26 | 1984-09-27 | Bristol Myers Co | |
| IL79519A0 (en) * | 1985-08-27 | 1986-10-31 | Bristol Myers Co | Bbm-1675c and d antitumor antibiotics |
| US4837206A (en) * | 1987-04-29 | 1989-06-06 | Bristol-Myers Company | Esperamicin derivatives |
| US4996305A (en) * | 1988-02-29 | 1991-02-26 | American Cyanamid Company | Process for producing the antibiotic and antitumor agents LL-E33288.epsilon.ε-Br |
| CA2027601A1 (en) * | 1989-11-06 | 1991-05-07 | Koko Sugawara | Antitumor antibiotic bu-3983t |
| GB0016020D0 (en) * | 2000-06-29 | 2000-08-23 | Inst Biomar Sa | New polyciclic xanthones and their use |
| CN115380211A (zh) * | 2021-03-17 | 2022-11-22 | 日本水产株式会社 | 精制的方法和经精制的产品 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4195079A (en) * | 1979-01-31 | 1980-03-25 | Pfizer Inc. | New polycyclic ether antibiotic |
| JPS56113791A (en) * | 1980-02-15 | 1981-09-07 | Kaken Pharmaceut Co Ltd | Novel antibiotic and its preparation |
| GR78648B (cs) * | 1982-07-26 | 1984-09-27 | Bristol Myers Co | |
| US4539203A (en) * | 1984-11-13 | 1985-09-03 | Warner-Lambert Company | CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use |
-
1984
- 1984-05-01 NZ NZ208013A patent/NZ208013A/en unknown
- 1984-05-08 CA CA000453762A patent/CA1241282A/en not_active Expired
- 1984-05-08 GR GR74646A patent/GR81581B/el unknown
- 1984-05-08 AU AU27791/84A patent/AU569294B2/en not_active Ceased
- 1984-05-11 ZA ZA843591A patent/ZA843591B/xx unknown
- 1984-05-11 FI FI841906A patent/FI81114C/fi not_active IP Right Cessation
- 1984-05-14 ES ES532476A patent/ES8700267A1/es not_active Expired
- 1984-05-14 IL IL71824A patent/IL71824A/xx unknown
- 1984-05-15 FR FR8407477A patent/FR2547594B1/fr not_active Expired
- 1984-05-15 SU SU843744582A patent/SU1344249A3/ru active
- 1984-05-15 LU LU85362A patent/LU85362A1/fr unknown
- 1984-05-15 BE BE0/212942A patent/BE899667A/fr not_active IP Right Cessation
- 1984-05-15 IT IT20928/84A patent/IT1175498B/it active
- 1984-05-15 DE DE19843418023 patent/DE3418023A1/de active Granted
- 1984-05-15 SE SE8402619A patent/SE460364B/sv not_active IP Right Cessation
- 1984-05-15 IE IE1200/84A patent/IE57444B1/en not_active IP Right Cessation
- 1984-05-15 HU HU841877A patent/HU193928B/hu not_active IP Right Cessation
- 1984-05-15 GB GB08412368A patent/GB2141425B/en not_active Expired
- 1984-05-15 DK DK239784A patent/DK163127C/da not_active IP Right Cessation
- 1984-05-16 KR KR1019840002636A patent/KR840008817A/ko not_active Ceased
- 1984-05-16 NL NL8401572A patent/NL8401572A/nl not_active Application Discontinuation
- 1984-05-16 YU YU849/84A patent/YU43846B/xx unknown
- 1984-05-16 AT AT0160984A patent/AT393691B/de not_active IP Right Cessation
- 1984-05-16 JP JP59096758A patent/JPS59232094A/ja active Granted
- 1984-05-16 PT PT78590A patent/PT78590A/pt not_active IP Right Cessation
-
1988
- 1988-11-21 KE KE3846A patent/KE3846A/xx unknown
-
1989
- 1989-02-02 HK HK98/89A patent/HK9889A/xx unknown
- 1989-05-04 KR KR1019890006047A patent/KR920001366B1/ko not_active Expired
- 1989-07-21 CY CY1465A patent/CY1465A/en unknown
- 1989-08-24 JP JP1216009A patent/JPH02128693A/ja active Granted
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE5508T1 (de) | Praeparate zur parenteralen verabreichung fettloeslicher wirkstoffe. | |
| CA2033725A1 (en) | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid | |
| AU585495B2 (en) | Pharmaceutical composition for the treatment of acute myocardial ischemia | |
| AU2746695A (en) | Metalloproteinase inhibitors | |
| ES468475A1 (es) | Procedimiento para la preparacion de derivados de cefem | |
| IL53594A (en) | Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them | |
| MY101784A (en) | Novel pharmacological compounds | |
| MY102929A (en) | Aqueous pharmaceutical formulations of piroxicam monohydrate | |
| BE899667A (fr) | Nouveau complexe antibiotique antitumoral dit bbm-1675. | |
| NO20005332L (no) | 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding | |
| AU583255B2 (en) | New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions | |
| GR852395B (cs) | ||
| BE902670A (fr) | Compose antibiotique antitumoral. | |
| IE44445L (en) | Pseudomonic acid amides | |
| DE3260277D1 (en) | Peptide antibiotic, component b, process for its preparation and its use in medicines | |
| ES8600758A1 (es) | Procedimiento para preparar derivados de1,3-dioxolanilo | |
| JPS57142999A (en) | Antibiotic compound, manufacture and medical use | |
| JPS61178914A (ja) | ヒト及び動物の耳への局所投与用不溶性薬剤 | |
| BE898807A (fr) | Luzopeptine e2 | |
| DK415185D0 (da) | Antibiotisk aktive forbindelser, fremgangsmaade til deres fremstilling, farmaceutiske kompositioner indeholdende forbindelserne og mikroorganisme anvendelig ved forbindelsernes fremstilling | |
| GB1299037A (en) | Dithiocarbamic acid esters | |
| AU6642781A (en) | Administration of medical active substances | |
| Glew et al. | In vitro susceptibility of Haemophilus aphrophilus to several antibiotics, alone and in combination | |
| FR2567755B1 (fr) | Nouveau medicament anti-tumoral contenant comme ingredient actif le triacetoxy-1,8,9 anthracene | |
| CA945544A (en) | 16-METHYLENE-9.beta., 10.alpha.-STEROID COMPOUNDS, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN THE NOVEL COMPOUNDS AS ACTIVE INGREDIENTS, AND METHODS OF PRODUCING THE SAID COMPOUNDSAND PREPARATIONS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: BRISTOL-MYERS CY Effective date: 19960531 |